MedTrace Logo

Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment

NCT03511690 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 95

Last updated 2022-04-25

No results posted yet for this study

Summary

Participating in genetic cancer risk assessments (GCRA) for hereditary breast and ovarian cancer can inform treatment and risk management decisions and improve breast cancer outcomes. However, Latina and Black women underuse GCRA services, which may increase breast cancer disparities. This study will adapt and test the impact of an easily scalable novel Tutoring System intervention to enhance GCRA use and improve psychosocial outcomes in a clinical sample of underserved Latina and Black women at risk of hereditary breast and ovarian cancer.

Conditions

  • Hereditary Breast and Ovarian Cancer

Interventions

BEHAVIORAL

BRCA-Gist

BRCA-gist is an innovative Intelligent Tutoring System intervention that uses avatars to emulate tailored one-to-one human tutoring and includes the bottom-line meaning of risk messages. BRCA-gist is designed to provide the same information contained in four modules from the NCI webpages: "breast cancer and metastasis," "risk factors," "genetic mutation testing," and "the consequences of testing.

Sponsors & Collaborators

  • Virginia Commonwealth University

    collaborator OTHER

  • Cornell University

    collaborator OTHER

  • Georgetown University

    lead OTHER

Principal Investigators

  • Alejandra H Hurtado de Mendoza, PhD · Georgetown University

  • Vanessa Sheppard, PhD · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2022-02-20
Completion
2022-02-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03511690 on ClinicalTrials.gov